NT-proBNP can predict outcome in patients with hypertension and LVH without left ventricular dysfunction or renal disease, independently of traditional cardiovascular risk factors including high blood pressure, renal function and electrocardiographic indexes[6]. This evidence concerns the gene NPPB and hypertensive disorder.